fluorodeoxyglucose f18 has been researched along with Extracapsular Extension in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Born, D; Broglie, MA; Hüllner, MW; Kovacs, Z; Maurer, A; Morand, GB; Nemes, CM; Nemmour, A; Pazahr, S; Rupp, NJ; Serrallach, B; Stadler, TM; Stoeckli, SJ | 1 |
| Arimura, H; Kai, Y; Matsuyama, T; Murakami, D; Nakayama, H; Orita, Y; Oya, N; Saito, T; Sakamoto, F; Shiraishi, S; Toya, R; Tsuda, N; Watakabe, T; Yoshida, R | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Extracapsular Extension
| Article | Year |
|---|---|
Prediction of extranodal extension in oropharyngeal cancer patients and carcinoma of unknown primary: value of metabolic tumor imaging with hybrid PET compared with MRI and CT.
Topics: Extranodal Extension; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Neoplasms, Unknown Primary; Oropharyngeal Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tomography, X-Ray Computed | 2023 |
Diagnostic Value of FDG-PET/CT for the Identification of Extranodal Extension in Patients With Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Aged; Extranodal Extension; Female; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Squamous Cell Carcinoma of Head and Neck | 2020 |